Skip to main content
. 2014 Sep 4;178(1):48–56. doi: 10.1111/cei.12394

Fig 1.

Fig 1

Expression of interleukin (IL)-1 beta and its soluble receptors I and II (sIL-1RI and sIL-1RII) in homogenate samples of lesional skin from 16 patients with pyoderma gangrenosum (PG) and six patients with Sweet's syndrome (SS). Six normal subjects (NS) served as controls. Numerical values represent signal intensity in a cytokine array assay.